SunnyBay BioTech, Inc. — Form D
SunnyBay BioTech, Inc. of FREMONT, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-27. The offering totals $6.0M, of which $2.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-27
- Form: D
- Accession: 0001963621-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $2.2M
- Remaining: $3.7M
- Investors: 3
- Date of first sale: 2023-01-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-471950
Issuer
- Name: SunnyBay BioTech, Inc.
- CIK: 0001963621
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 46283 WARM SPRINGS BLVD., FREMONT, CA, 94539
- Phone: (512) 332-6968
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Peter Colabuono | Director | Belmont, CA |
| Xiangmin Cui | Director | Houston, TX |
| Feng Wang-Johanning | Director | Fremont, CA |
| Gary Johanning | Executive Officer | Fremont, CA |
| Feng Wang-Johanning | Executive Officer | Fremont, CA |
More